Endocan Level in Patients With Erectile Dysfunction and Relationship With Tadalafil Treatment
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 90
- Locations
- 1
- Primary Endpoint
- Rates of IIEF Score
Study Overview
Brief Summary
The investigators analyze the patients' endocan levels, IIEF scores, and hormon levels both before and after tadalafil (5 or 20mg) treatment. The investigators want to see erectile dysfunction severity and tadalafil treatment relations with endocen level.
Detailed Description
The investigators will include at least 90 patients in study. Blood tests will taken before and after tadalafil treatment and will store at -80 celcius degree.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Diagnostic
- Masking
- Single (Participant)
Eligibility Criteria
- Ages
- 18 Years to 65 Years (Adult, Older Adult)
- Sex
- Male
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Patients with erectile dysfuction
Exclusion Criteria
- •Psychogenic erectile dysfunction
- •Erectile dysfunction associated with hormonal disorders
- •Drug related erectile dysfunction
Arms & Interventions
20mg tadalafil
20 mg tadalafil
Intervention: Endocan (Diagnostic Test)
5mg tadalafil
5mg tadalafil
Intervention: Endocan (Diagnostic Test)
5mg tadalafil
5mg tadalafil
Intervention: tadalafil (Drug)
20mg tadalafil
20 mg tadalafil
Intervention: tadalafil (Drug)
Outcomes
Primary Outcomes
Rates of IIEF Score
Time Frame: 1 month
Levels of Endocan relationship with IIEF
Secondary Outcomes
- Levels of Endocan(1 month)
Investigators
Veysel Bayburtluoğlu
Principal Investigator
Ankara Training and Research Hospital